United Services Automobile Association Repligen Corp Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$76.65 - $95.51 $10.4 Million - $13 Million	-136,301 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$54.2 - $85.95 $21,409 - $33,950	-395 Reduced 0.29%	136,301 $11.7 Million
Q1 2019 May 13, 2019	BUY	$49.45 - $62.8 $855,287 - $1.09 Million	17,296 Added 14.49%	136,696 $8.08 Million
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $127,551 - $182,049	2,643 Added 2.26%	119,400 $6.3 Million
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $1.28 Million - $1.62 Million	27,400 Added 30.66%	116,757 $6.48 Million
Q2 2018 Aug 10, 2018	BUY	$35.26 - $47.04 $289,132 - $385,728	8,200 Added 10.1%	89,357 $4.2 Million
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $2.26 Million - $2.72 Million	73,047 Added 900.7%	81,157 $2.94 Million
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $263,818 - $315,641	8,110	8,110 $294,000

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.